Navigation Links
VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions
Date:8/17/2010

CORAL SPRINGS, Fla., Aug. 17 /PRNewswire/ -- VirtuOx, Inc., a medical technology services company and industry leader in delivering home sleep testing solutions, today announced an agreement with Watermark Medical, a privately-held, medical products and services company currently servicing the sleep-disordered breathing market, to utilize the Watermark ARES™ device in its portfolio, the VirtuOx Home Sleep Test (HoST™) solutions.

VirtuOx's HoST™ home sleep testing platforms can diagnose patients with the two most common forms of Sleep Apnea - Central and Obstructive - in the comfort and privacy of their home. With VirtuOx solutions, which now include Watermark ARES, a patient never has to leave home to be diagnosed with sleep apnea. VirtuOx delivers the device to the patient's home, supplies detailed instructions and 24-hour telephone support and provides an accurate diagnosis using its network of Board Certified Sleep Physicians.

"We are very excited about enhancing our nationwide HoST™ (Home Sleep Testing) delivery platform with the Watermark Medical Apnea Risk Evaluation System (ARES™)," said Felix Krupczynski, COO of VirtuOx.  "After reviewing all of the HoST products available today, VirtuOx chose Watermark Medical's sleep platform because it combines the scalability and flexibility of cloud computing with a user-friendly web interface that enables higher accuracy and accessibility for healthcare providers and patients. Clinically and operationally, it is an outstanding device that enables us to enhance our national service by adding Level II clinical testing to our market-leading home sleep testing program, as well as provide patients with an easy to use, in-home diagnostic option."

Watermark ARES (Apnea Risk Evaluation System) is the first FDA-cleared, CMS approved, in-home, wire-free, ambulatory sleep test device that provides physicians with a highly accurate, lower-cost tool to diagnose patients who may be suffering from Obstructive Sleep Apnea (OSA). The ARES™ integrates physiological data acquired in-home with clinical history and anthropomorphic data to determine the presence and severity of OSA.  

"With this strategic alliance, Watermark and VirtuOx are making in-home testing and diagnosis even more accessible to the millions of Americans suffering from sleep apnea," said Charlie Alvarez, Co-Founder and President of Watermark Medical. "The ARES device can save patients significant time and money, but can also save lives. Since sleep apnea is linked to chronic health conditions such as obesity, heart disease, diabetes and hypertension, accurate and timely diagnosis is critical. With VirtuOx's HoST platform, now with Watermark ARES, patients can be diagnosed and treated quickly, resulting in a decrease in long-term health problems – even death. A partnership between Watermark Medical and VirtuOx signifies that we are one step closer to making at-home medical diagnosis part of our overall healthcare system."  

The VirtuOx HoST solution, now enhanced with the Watermark ARES device, enables patients throughout the country to be easily and cost-effectively diagnosed with Obstructive Sleep Apnea.

For more information, visit www.virtuox.net.

About VirtuOx, Inc.

VirtuOx, Inc. is a privately held medical technology services company that provides diagnostic tools and services that enable a variety of healthcare organizations and professionals in diagnosing and treating Respiratory diseases through vertically integrated platforms, products and services.  VirtuOx' platforms includes a Medicare approved, Independent Diagnostic Testing Facility (IDTF) that assists in the diagnosis and qualification of treatment options for Sleep Disorder Breathing and Respiratory Diseases in the home, industry leading web-based management applications that communicate with physicians, medical equipment providers and patients globally as well as product and distribution offerings.  

About Watermark Medical, LLC.

Watermark Medical, LLC., (WM) is a privately held medical products company servicing the sleep-disordered breathing market.  Its co-founders/investors are serial entrepreneurs with extensive experience building successful business models and sales and distribution channels for medical services.  WM's recent experience was with CardioNet, Inc., a reimbursement-based, medical services company focused on cardiac arrhythmia monitoring.  The company is headquartered in Boca Raton, FL.  For more information, visit www.watermarkmedical.com.


'/>"/>
SOURCE VirtuOx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010
2. Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27
3. UCI Medical Affiliates, Inc. Reports Third Quarter Results for Fiscal Year 2010
4. Medco Announces Agreement to Acquire United BioSource Corporation: A Global Medical Research and Scientific Services Leader to Advance Drug Safety and Knowledge
5. China Medical Technologies Reports First Fiscal Quarter Financial Results
6. Michigan Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities Under Medicare
7. California Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People with Disabilities Under Medicare
8. New York Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities
9. ProUroCare Medical Inc. Announces Completion of Warrant Replacement Offering
10. Invivo Wins Medical Design Excellence Award for Prostate Solutions
11. Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 2016 , ... Beleza Medspa has initiated a new program to ... the first time that Coolsculpting is being used for for more than just cosmetic ... they meet the prescribed body-fat standard, measured by the circumference-based tape method. The ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year Standard ... Allison Outerbridge is this year’s Life University winner of a $2,500 ... university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter at ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a hot ... suggests that Americans prefer their dogs straight off the grill. Of the 90 percent ... favorite way to cook a hot dog, far outpacing other cooking methods such as ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... outcomes, hosted members and suppliers for its inaugural Member Conference at the Paris ... mission of elevating the operational health of America’s healthcare providers. , The conference ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For Heroes ... in military battle for the country. The nonprofit Hope For Heroes partnered with ... that empower independence for disabled military veterans, as well as police, firemen, and EMS ...
Breaking Medicine News(10 mins):